IFP Advisors Inc Acquires 1,279 Shares of Hims & Hers Health, Inc. $HIMS

IFP Advisors Inc increased its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 154.3% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 2,108 shares of the company’s stock after purchasing an additional 1,279 shares during the period. IFP Advisors Inc’s holdings in Hims & Hers Health were worth $114,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in HIMS. Nuveen LLC acquired a new stake in shares of Hims & Hers Health in the first quarter valued at approximately $58,403,000. Yong Rong HK Asset Management Ltd increased its stake in shares of Hims & Hers Health by 41.2% during the first quarter. Yong Rong HK Asset Management Ltd now owns 2,400,000 shares of the company’s stock worth $70,920,000 after purchasing an additional 700,100 shares during the period. CloudAlpha Capital Management Limited Hong Kong bought a new position in shares of Hims & Hers Health during the first quarter worth approximately $20,580,000. Jump Financial LLC increased its stake in shares of Hims & Hers Health by 633.2% during the first quarter. Jump Financial LLC now owns 725,445 shares of the company’s stock worth $21,437,000 after purchasing an additional 626,496 shares during the period. Finally, Northern Trust Corp increased its stake in shares of Hims & Hers Health by 19.5% during the first quarter. Northern Trust Corp now owns 2,435,512 shares of the company’s stock worth $71,969,000 after purchasing an additional 397,310 shares during the period. 63.52% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on HIMS shares. UBS Group set a $30.00 target price on Hims & Hers Health in a research note on Monday, June 23rd. Wall Street Zen lowered Hims & Hers Health from a “buy” rating to a “hold” rating in a research note on Monday, July 28th. Needham & Company LLC reiterated a “hold” rating on shares of Hims & Hers Health in a research note on Tuesday, August 5th. Citigroup restated a “sell” rating on shares of Hims & Hers Health in a research note on Monday, June 23rd. Finally, Truist Financial lowered their price objective on Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating on the stock in a research note on Monday, August 18th. Two research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $38.92.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, insider Michael Chi sold 900 shares of Hims & Hers Health stock in a transaction dated Friday, October 10th. The stock was sold at an average price of $58.25, for a total transaction of $52,425.00. Following the transaction, the insider directly owned 291,439 shares of the company’s stock, valued at approximately $16,976,321.75. The trade was a 0.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Patrick Harrison Carroll sold 10,021 shares of Hims & Hers Health stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $50.50, for a total value of $506,060.50. Following the transaction, the insider directly owned 169,940 shares in the company, valued at $8,581,970. The trade was a 5.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,561,799 shares of company stock worth $80,686,085 over the last 90 days. 13.71% of the stock is currently owned by company insiders.

Hims & Hers Health Trading Down 15.9%

Shares of HIMS opened at $49.77 on Friday. The company has a debt-to-equity ratio of 1.72, a quick ratio of 4.46 and a current ratio of 4.98. Hims & Hers Health, Inc. has a 52-week low of $18.33 and a 52-week high of $72.98. The firm has a market cap of $11.25 billion, a price-to-earnings ratio of 62.21, a PEG ratio of 3.40 and a beta of 2.25. The business’s fifty day moving average is $51.01 and its 200-day moving average is $48.89.

Hims & Hers Health (NYSE:HIMS) last released its quarterly earnings data on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. The firm had revenue of $544.83 million for the quarter, compared to analyst estimates of $550.06 million. During the same period last year, the business earned $0.06 EPS. The company’s revenue was up 72.6% compared to the same quarter last year. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.